Clinical trial Recruiting at 1 site Interventional Ages 55 to 100

Combining endoscopic cyclophotocoagulation with cataract surgery for normal tension glaucoma

Official title: Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma

Run by Helsinki University Central Hospital · NCT04651530 · Data updated 2026-11-12

This study is testing if adding a special eye treatment during cataract surgery can help people with normal tension glaucoma lower their eye pressure better than cataract surgery alone.

Quick facts

Study typeInterventional
Ages55 Years to 100 Years
SexAll
Enrollment100 (estimated)
SponsorHelsinki University Central Hospital
Academic / other
Locations1 site (Helsinki)
StatusRecruiting
StartedDecember 8, 2020
Main results expectedDecember 1, 2025
Study endsDecember 1, 2026
Registry record updatedDecember 22, 2020
Trial IDNCT04651530 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with stable normal tension glaucoma and clinically significant cataracts who are currently on medication.

Probably not a fit

Patients with secondary glaucoma or those who have had previous glaucoma surgeries are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of adding endoscopic cyclophotocoagulation (ECP) to cataract surgery in patients with normal tension glaucoma. Participants with stable glaucoma who require cataract surgery will be randomly assigned to receive either ECP during their cataract surgery or cataract surgery alone. The primary goal is to determine if the combination procedure results in lower intraocular pressure compared to cataract surgery by itself. The study aims to provide insights into improving treatment outcomes for patients with this specific type of glaucoma.

Why it matters

Potential benefit: If successful, this approach could lead to better management of intraocular pressure in patients with normal tension glaucoma undergoing cataract surgery.

How similar studies have gone: Other studies have shown promising results with similar surgical approaches, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Signed Informed Consent
* Normal Tension Glaucoma with typical nerve fiber layer defects in red-free photographs and/or optical coherence tomography (OCT) and possible equivalent visual field defects, IOP never more than 21 mmHg, and open anterior chamber angle
* Glaucoma stable with current medication assessed by a glaucoma specialist
* Clinically significant cataract

Exclusion Criteria:

* Secondary Glaucoma e.g. due to previous injury or uveitis
* Exfoliation syndrome
* Pigment dispersion syndrome
* Previous transscleral or endoscopic cyclophotocoagulation
* Previous other glaucoma surgery
* Cataract due to eye injury or congenital cataract
* Zonular weakness due to Marfan syndrome or other
* Previous retinal detachment
* Previous intraocular surgery like vitrectomy and other retinal surgery
* Wet age-related macular degeneration
* Diabetic retonopathy
* Previous corneal transplant or previous refractive surgery
* Fuchs' dystrophy and other abnormalities compromising corneal clarity like scars
* The patient does not want to participate in the study
* The glaucoma progresses on current IOP
* The patient does not speak Finnish, Swedish or English
* Dementia
* Only eye with vision worse than 20/200 or loss of central visual field

Where it's running

  • Helsinki University Hospital
    Helsinki, Finland
    Recruiting

Study contacts

  • Principal investigator: Mika Harju, MD, PhD — Helsinki University Central Hospital
  • Study coordinator: Nina M Lindbohm, MD, PhD
  • Email: nina.lindbohm@hus.fi
  • Phone: +358505715668

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.